The Netherlands has become the latest country to suspend use of the Oxford-AstraZeneca coronavirus vaccine over concerns about possible side effects.
The World Health Organization and the European Medicines Agency say there is no indication of a link between the vaccine and reports of blood clots.
Seven countries have so far fully suspended the AstraZeneca vaccinations.
Experts say cases of clotting in vaccinated people are lower than the number seen in the general population.
About 17 million people in the EU and the UK have received a dose of the vaccine, with fewer than 40 cases of blood clots reported as of last week, AstraZeneca said.
The Dutch government said its suspension, which will last until at least 29 March, was a precaution.